Physician profile
Mostaque Ahmed
NPI 1003851064
$509.81
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $64.14 · 2021: $85.03 · 2022: $113 · 2023: $30.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $90.96 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $88.77 | 2022 | |
| Glaxosmithkline, LLC. | $68.30 | 2019 | |
| Vapotherm INC | $61.96 | 2021-2023 | Vapotherm |
| Global Blood Therapeutics, INC. | $53.78 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.14 | 2020 | |
| Smith+Nephew, INC. | $26.13 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.05 | 2022 | |
| Janssen Biotech, INC. | $22.66 | 2019 | |
| Sunovion Pharmaceuticals INC. | $21.43 | 2019 | |
| Pfizer INC. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mostaque Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.